Michael Clayman
Chairman presso Anokion SA
Profilo
Michael D.
Clayman is the founder of Flexion Therapeutics, Inc., which was founded in 2007.
He held the title of President, Chief Executive Officer & Director from 2018 to 2021.
Currently, he is the Non-Executive Chairman at Anokion SA since 2016, Chairman at Ribometrix, Inc. since 2019, Chairman at Nido Biosciences, Inc. since 2022, and Director at Kanyos Bio, Inc. He previously worked as an Independent Director at Akebia Therapeutics, Inc. from 2014 to 2018.
He also held positions at Eli Lilly & Co., Abbott Cardiovascular Systems, Inc., Chorus Group Ltd., Lilly Research Laboratories, and Perelman School of Medicine.
He completed his undergraduate degree at Yale University and obtained a doctorate from UC San Diego School of Medicine.
Posizioni attive di Michael Clayman
| Società | Posizione | Inizio |
|---|---|---|
Anokion SA
 Anokion SA Medical/Nursing ServicesHealth Services Anokion SA provides technology for retraining white blood cells to induce therapeutic immune tolerance. The firm?s approach to antigen-specific immune tolerance can be translated to virtually any protein in numerous clinical indications. The company was founded by Jerffery Hubbell, Melody Swartz, Stephan Kontos, Oscar Buset, Kristen M. Lorentz and David A. Lowin and is headquartered in Ecublens, Switzerland. | Chairman | 14/06/2018 |
Kanyos Bio, Inc.
 Kanyos Bio, Inc. Pharmaceuticals: MajorHealth Technology Kanyos Bio, Inc. engages in the provision of immune tolerance technology solutions. It develops antigen-specific for treatment of type-1 diabetes and celiac disease. The company was founded by Jeffrey Hubbell, Stephan Kontos, Oscar Buset, Kristen M. Lorentz, and David A. Lowin in 2015 and is headquartered in Cambridge, MA. | Director/Board Member | - |
Ribometrix, Inc.
 Ribometrix, Inc. Pharmaceuticals: MajorHealth Technology Ribometrix, Inc. develops small molecule drugs that target functional RNA structures to create new avenues to treat human disease. The company was founded by Kevin Weeks and Katie Warner and is headquartered in Greenville, NC. | Chairman | 27/09/2019 |
Nido Biosciences, Inc.
 Nido Biosciences, Inc. BiotechnologyHealth Technology Nido Biosciences, Inc. focuses on developing small molecule therapeutics for the treatment of neurodegenerative diseases. The company is headquartered in Boston, MA. | Chairman | 01/08/2022 |
Precedenti posizioni note di Michael Clayman
| Società | Posizione | Fine |
|---|---|---|
| FLEXION THERAPEUTICS, INC. | Chief Executive Officer | 19/11/2021 |
| AKEBIA THERAPEUTICS, INC. | Director/Board Member | 12/12/2018 |
Lilly Research Laboratories
 Lilly Research Laboratories Miscellaneous Commercial ServicesCommercial Services Part of Eli Lilly & Co., Lilly Research Laboratories is a private company that engages in research and develops medicines. The company is based in Indianapolis, IN. | Corporate Officer/Principal | 01/01/2007 |
Abbott Cardiovascular Systems, Inc.
 Abbott Cardiovascular Systems, Inc. Medical SpecialtiesHealth Technology Abbott Cardiovascular Systems, Inc. manufactures medical devices. It also makes cardiac and peripheral vascular repair surgical systems. The company was founded in 1978 and is headquartered in Santa Clara, CA. | General Counsel | - |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | - |
Formazione di Michael Clayman
| Yale University | Undergraduate Degree |
| UC San Diego School of Medicine | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| ELI LILLY AND COMPANY | Health Technology |
| AKEBIA THERAPEUTICS, INC. | Health Technology |
| Aziende private | 8 |
|---|---|
Flexion Therapeutics, Inc.
 Flexion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Flexion Therapeutics, Inc. operates as a biopharmaceutical company, which engages in the development and commercialization of novel and local therapies. It specializes in the treatment of patients with musculoskeletal conditions including osteoarthritis. It offers products under the Zilretta brand, an extended-release corticosteroid approved to manage osteoarthritis knee pain. The company was founded by Michael D. Clayman and Neil Bodick on November 5, 2007 and is headquartered in Burlington, MA. | Health Technology |
Abbott Cardiovascular Systems, Inc.
Abbott Cardiovascular Systems, Inc. Medical SpecialtiesHealth Technology Abbott Cardiovascular Systems, Inc. manufactures medical devices. It also makes cardiac and peripheral vascular repair surgical systems. The company was founded in 1978 and is headquartered in Santa Clara, CA. | Health Technology |
Chorus Group Ltd.
 Chorus Group Ltd. Engineering & ConstructionIndustrial Services Chorus Group Ltd. provides interior design and refurbishment services. It offer services to leisure, retail and public sectors, commercial offices and hotels. The company was founded on February 26, 1996 and is headquartered in Barnet, the United Kingdom. | Industrial Services |
Lilly Research Laboratories
Lilly Research Laboratories Miscellaneous Commercial ServicesCommercial Services Part of Eli Lilly & Co., Lilly Research Laboratories is a private company that engages in research and develops medicines. The company is based in Indianapolis, IN. | Commercial Services |
Anokion SA
Anokion SA Medical/Nursing ServicesHealth Services Anokion SA provides technology for retraining white blood cells to induce therapeutic immune tolerance. The firm?s approach to antigen-specific immune tolerance can be translated to virtually any protein in numerous clinical indications. The company was founded by Jerffery Hubbell, Melody Swartz, Stephan Kontos, Oscar Buset, Kristen M. Lorentz and David A. Lowin and is headquartered in Ecublens, Switzerland. | Health Services |
Kanyos Bio, Inc.
Kanyos Bio, Inc. Pharmaceuticals: MajorHealth Technology Kanyos Bio, Inc. engages in the provision of immune tolerance technology solutions. It develops antigen-specific for treatment of type-1 diabetes and celiac disease. The company was founded by Jeffrey Hubbell, Stephan Kontos, Oscar Buset, Kristen M. Lorentz, and David A. Lowin in 2015 and is headquartered in Cambridge, MA. | Health Technology |
Ribometrix, Inc.
Ribometrix, Inc. Pharmaceuticals: MajorHealth Technology Ribometrix, Inc. develops small molecule drugs that target functional RNA structures to create new avenues to treat human disease. The company was founded by Kevin Weeks and Katie Warner and is headquartered in Greenville, NC. | Health Technology |
Nido Biosciences, Inc.
Nido Biosciences, Inc. BiotechnologyHealth Technology Nido Biosciences, Inc. focuses on developing small molecule therapeutics for the treatment of neurodegenerative diseases. The company is headquartered in Boston, MA. | Health Technology |
- Borsa valori
- Insiders
- Michael Clayman
